We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Bowel Cancer Linked to High Dietary Iron and Defective Gene Function

By LabMedica International staff writers
Posted on 21 Aug 2012
The combination of high dietary iron content and defective functioning of the APC (adenomatous polyposis coli) gene has been found to increase the risk of developing bowel cancer significantly.

The APC gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. More...
It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant premalignant disease that usually progresses to malignancy.

Investigators at the University of Birmingham (United Kingdom) and the Beatson Institute for Cancer Research (Glasgow, United Kingdom) published a study in the August 9, 2012, online edition of the journal Cell Reports that linked APC mutations and high dietary iron content to the development of bowel cancer.

They showed in a mouse model system that after APC deletion the cellular iron acquisition proteins TfR1 and DMT1 were rapidly induced. Conversely, restoration of APC reduced cellular iron due to repression of these proteins. To test the functional importance of these findings, they performed in vivo investigations of the impact of iron levels on intestinal tumor development. Strikingly, depletion of luminal (but not systemic) iron strongly suppressed tumor development in intestines of the mice, whereas increased luminal iron strongly promoted tumor development.

Bowel cancers were two to three times more likely to develop in mice with a faulty APC gene that were fed high amounts of iron compared to mice with a fully functioning APC gene. In contrast, mice with a faulty APC gene fed a diet low in iron did not develop bowel cancer at all.

Senior author Dr. Owen Sansom, deputy director of the for cancer research at the Beatson Institute for Cancer Research, said, "We have made a huge step in understanding how bowel cancer develops. The APC gene is faulty in around eight out of 10 bowel cancers but until now we have not known how this causes the disease. It is clear that iron is playing a critical role in controlling the development of bowel cancer in people with a faulty APC gene. And, intriguingly, our study shows that even very high levels of iron in the diet do not cause cancer by itself, but rely on the APC gene."

Results obtained during this study could explain why foods such as red meat, which have high levels of iron, are linked to an increased risk of bowel cancer.

Related Links:
University of Birmingham
Beatson Institute for Cancer Research




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.